Skip to Content

M 571 (Terbinafine 250 mg)

Pill imprint M 571 has been identified as Terbinafine hydrochloride 250 mg.

Terbinafine is used in the treatment of tinea corporis; cutaneous candidiasis; onychomycosis, toenail; tinea capitis; tinea cruris (and more), and belongs to the drug class miscellaneous antifungals. There is no proven risk in humans during pregnancy. Terbinafine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Terbinafine hydrochloride 250 mg M 571
Terbinafine hydrochloride 250 mg M 571
Terbinafine hydrochloride
M 571
250 mg
16.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Miscellaneous antifungals
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
microcrystalline cellulose

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.